Metabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory Actions
Open Access
- 1 August 2006
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 281 (32), 22847-22854
- https://doi.org/10.1074/jbc.m603766200
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: Novel oxygenase products from ω-3 polyunsaturated fatty acidsBiochemical and Biophysical Research Communications, 2005
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulationBioorganic & Medicinal Chemistry, 2005
- Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1The Journal of Experimental Medicine, 2005
- Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETEProgress in Lipid Research, 2005
- Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma GONDIINature Reviews Immunology, 2005
- Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airwayNature Immunology, 2004
- Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analogKidney International, 2003
- International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin ReceptorsPharmacological Reviews, 2003
- Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.JCI Insight, 1998